Abstract
We report two cases of children with severe cardiomyopathy requiring treatment with ventricular assist devices who developed acute kidney injury and were treated with fenoldopam. Therapy with fenoldopam appeared successful in one case in that renal replacement therapy was avoided with improvement in urine output and renal function. These are the first reported cases of fenoldopam use in children with acute kidney injury receiving mechanical circulatory support.
References
Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA (2006) Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation 113:2313–2319
Reinhartz O, Hill JD, Al-Khaldi A, Pelletier MP, Robbins RC, Farrar DJ (2005) Thoratec ventricular assist devices in pediatric patients: update on clinical results. ASAIO J 51:501–503
Kaltenmaier B, Pommer W, Kaufmann F, Hennig E, Molzahn M, Hetzer R (2000) Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO J 46:330–333
Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, Ranucci M, Zangrillo A (2007) Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49:56–68
Moffett BS, Orellana R (2006) Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report. Pediatr Crit Care Med 7:600–602
Costello JM, Thiagarajan RR, Dionne RE, Allan CK, Booth KL, Burmester M, Wessel DL, Laussen PC (2006) Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 7:28–33
Lechner BL, Pascual JF, Roscelli JD (2005) Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient. Mil Med 170:130–132
Strauser LM, Pruitt RD, Tobias JD (1999) Initial experience with fenoldopam in children. Am J Ther 6:283–288
Tobias JD (2000) Fenoldopam for controlled hypotension during spinal fusion in children and adolescents. Paediatr Anaesth 10:261–266
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143
Kellum JA, Decker MJ (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531
Lauschke A, Teichgraber UK, Frei U, Eckardt KU (2006) ‘Low-dose’ dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69:1669–1674
Murphy MB, Murray C, Shorten GD (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345:1548–1557
Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR (1999) The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27:1832–1837
Shusterman NH, Elliott WJ, White WB (1993) Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 95:161–168
Bove T, Landoni G, Calabro MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A (2005) Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111:3230–3235
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knoderer, C.A., Leiser, J.D., Nailescu, C. et al. Fenoldopam for acute kidney injury in children. Pediatr Nephrol 23, 495–498 (2008). https://doi.org/10.1007/s00467-007-0659-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0659-z